Brief: Kronos Bio Inc Says Kb-0742 Reduced Tumor Growth In Castration-Resistant Prostate Cancer
22/10/2020 13:08
Oct 22 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO INC - KB-0742 INHIBITED ANDROGEN
RECEPTOR-DEPENDENT
ACTIVITY AND REDUCED TUMOR GROWTH IN CASTRATION-RESISTANT
PROSTATE CANCER
* KRONOS BIO INC - ON TRACK TO SUBMIT AN IND IN Q4 OF 2020
AND
INITIATE PHASE 1/2 CLINICAL TRIAL FOR ADVANCED SOLID TUMORS IN
2021
Source text for Eikon: ID:nGNX9m0Ywp
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems